← Leaderboards
Zhenyuan Song
University Of Louisville
$5,761,422
Attributed
$5,761,422
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $779.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,761,422 · 5
By mechanism
R01$4,816,013 · 3
K01$525,672 · 1
R21$419,737 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Craig J McClain$36,863,296
- Kenneth R McLeish$810,652
- M Michele Pisano$144,958
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayAlcoholsAlcoholic Liver DiseasesAlcohol ExposureChronic Alcohol IngestionUnited StatesChronicLiverFatty LiverBasePathogenesisPathway InteractionsFibrosisCell Culture TechniquesCirrhosisSteatohepatitisAlcohol EffectFeedingReportingReactionHepaticMetabolismAlcohol ConsumptionHepatocyte
Grant awards (21)
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease$387,826
R01 · FY2025 · AA · contact PI
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease$393,583
R01 · FY2024 · AA · contact PI
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease$396,461
R01 · FY2023 · AA · contact PI
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease$419,459
R01 · FY2022 · AA · contact PI
Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease$359,775
R01 · FY2022 · AA · contact PI
Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease$359,775
R01 · FY2021 · AA · contact PI
Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease$359,775
R01 · FY2020 · AA · contact PI
Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease$359,775
R01 · FY2019 · AA · contact PI
Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease$359,775
R01 · FY2018 · AA · contact PI
The pathological role of nicotinamide N-methyltransferase in alcoholic liver disease$229,856
R21 · FY2018 · AA · contact PI
The pathological role of nicotinamide N-methyltransferase in alcoholic liver disease$189,881
R21 · FY2017 · AA · contact PI
Homocysteine, Adiponectin, and Alcoholic Liver Disease$263,989
R01 · FY2013 · AA · contact PI
Homocysteine, Adiponectin, and Alcoholic Liver Disease$283,859
R01 · FY2012 · AA · contact PI
Homocysteine, Adiponectin, and Alcoholic Liver Disease$283,859
R01 · FY2011 · AA · contact PI
Homocysteine, Adiponectin, and Alcoholic Liver Disease$295,217
R01 · FY2010 · AA · contact PI
Homocysteine, Adiponectin, and Alcoholic Liver Disease$292,885
R01 · FY2009 · AA · contact PI
Mechanisms of Sensitization to TNF hepatotoxicity in ALD$110,347
K01 · FY2009 · AA · contact PI
Mechanisms of Sensitization to TNF hepatotoxicity in ALD$107,635
K01 · FY2008 · AA · contact PI
Mechanisms of Sensitization to TNF hepatotoxicity in ALD$105,003
K01 · FY2007 · AA · contact PI
Mechanisms of Sensitization to TNF hepatotoxicity in ALD$102,449
K01 · FY2006 · AA · contact PI
Mechanisms of Sensitization to TNF hepatotoxicity in ALD$100,238
K01 · FY2005 · AA